Prevention of altitude-related illness in patients with COPD by acetazolamide. RCT.
M. Furian (Zurich, Switzerland), A. Buergin (Zurich, Switzerland), P. Scheiwiller (Zurich, Switzerland), L. Mayer (Zurich, Switzerland), S. Schneider (Zurich, Switzerland), M. Mademilov (Bishkek, Kyrgyzstan), B. Emilov (Bishkek, Kyrgyzstan), M. Lichtblau (Zurich, Switzerland), L. Muralt (Zurich, Switzerland), U. Sheraliev (Bishkek, Kyrgyzstan), N. Marazhapov (Bishkek, Kyrgyzstan), T. Sooronbaev (Bishkek, Kyrgyzstan), S. Ulrich (Zurich, Switzerland), K. Bloch (Zurich, Switzerland)
Source: International Congress 2019 – Lung function and respiratory muscle testing
Session: Lung function and respiratory muscle testing
Session type: Poster Discussion
Number: 3938
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Furian (Zurich, Switzerland), A. Buergin (Zurich, Switzerland), P. Scheiwiller (Zurich, Switzerland), L. Mayer (Zurich, Switzerland), S. Schneider (Zurich, Switzerland), M. Mademilov (Bishkek, Kyrgyzstan), B. Emilov (Bishkek, Kyrgyzstan), M. Lichtblau (Zurich, Switzerland), L. Muralt (Zurich, Switzerland), U. Sheraliev (Bishkek, Kyrgyzstan), N. Marazhapov (Bishkek, Kyrgyzstan), T. Sooronbaev (Bishkek, Kyrgyzstan), S. Ulrich (Zurich, Switzerland), K. Bloch (Zurich, Switzerland). Prevention of altitude-related illness in patients with COPD by acetazolamide. RCT.. 3938
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: